TD Asset Management
PRAX icon

TD Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

TD Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.09M Sell
27,162
-7,984
-23% -$2.53M 0.01% 681
2026
Q1 		$11.3M Sell
35,146
-11,000
-24% -$3.4M 0.01% 617
2025
Q4 		$13.6M Buy
46,146
+5,262
+13% +$980K 0.01% 584
2025
Q3 		$2.17M Sell
40,884
-23,054
-36% -$1.12M ﹤0.01% 949
2025
Q2 		$2.69M Buy
63,938
+26,800
+72% +$1.02M ﹤0.01% 873
2025
Q1 		$1.41M Sell
37,138
-15,760
-30% -$984K ﹤0.01% 1031
2024
Q4 		$4.07M Buy
52,898
+9,000
+21% +$651K ﹤0.01% 834
2024
Q3 		$2.54M Sell
43,898
-7,414
-14% -$401K ﹤0.01% 955
2024
Q2 		$2.12M Buy
51,312
+16,312
+47% +$771K ﹤0.01% 979
2024
Q1 		$2.14M Buy
+35,000
New +$1.57M ﹤0.01% 1001

Other funds holding PRAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

TD Asset Management's PRAX Position: Q2 2026 in Review

TD Asset Management reduced its Praxis Precision Medicines (PRAX) stake by 23% in Q2 2026, selling an estimated $2.53M and leaving 27,162 shares worth $9.09M. The position accounts for 0.01% of the portfolio, ranked #681.

TD Asset Management first reported a position in PRAX in Q1 2024 and has held it in 10 quarters since. The position peaked at $13.6M in Q4 2025. 188 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • TD Asset Management held 27,162 shares of Praxis Precision Medicines worth $9.09M as of Q2 2026.
  • TD Asset Management sold 7,984 Praxis Precision Medicines shares in Q2 2026, an estimated $2.53M.
  • Praxis Precision Medicines made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #681 holding.
  • TD Asset Management first reported a position in Praxis Precision Medicines in Q1 2024 and has held it in 10 quarters since.
  • TD Asset Management's Praxis Precision Medicines position peaked at $13.6M in Q4 2025.
  • 188 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.